Topchoice Medical Corporation

Shanghai Stock Exchange 600763.SS

Topchoice Medical Corporation Price to Sales Ratio (P/S) on January 14, 2025: 6.31

Topchoice Medical Corporation Price to Sales Ratio (P/S) is 6.31 on January 14, 2025, a -19.46% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Topchoice Medical Corporation 52-week high Price to Sales Ratio (P/S) is 9.79 on October 08, 2024, which is 55.26% above the current Price to Sales Ratio (P/S).
Topchoice Medical Corporation 52-week low Price to Sales Ratio (P/S) is 4.22 on July 04, 2024, which is -33.15% below the current Price to Sales Ratio (P/S).
Topchoice Medical Corporation average Price to Sales Ratio (P/S) for the last 52 weeks is 6.76.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 600763.SS

Topchoice Medical Corporation

CEO	Ms. Yi Wang
IPO Date	Oct. 30, 1996
Location	China
Headquarters	Building 5
Employees	6,115
Sector	Health Care
Industries Dental Care Hospitals & Clinics Medical Instruments Pharmaceuticals

Description

Topchoice Medical Corporation provides medical services in China. It provides various specialty medical services in oral, reproductive, and ophthalmology areas; and operates dental medical institutions and assisted reproductive medical institutions. It operates approximately 32 dental hospitals; and Tongze Dental College, a non-profit educational training organization. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Corporation in November 2019. Topchoice Medical Corporation was founded in 1995 and is based in Hangzhou, China.

Key trends

Past 5 years